Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational […]
In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic […]
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain
Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain […]
As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer information throughout the year.
Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted […]
As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the […]
The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic […]
Cervical Cancer Survivors Face Long-term Risk of Second Cancers According to the results of a study published in the Journal […]
Cervical Cancer Survivors Face Risk of Second Cancers According to the results of a study presented at the 2007 annual […]
Possible Role for Avastin® in Recurrent Cervical Cancer A small study of six patients suggests that the combination of Avastin® […]
Stress and Depression Frequent Among Women Treated for Gynecological Cancers According to the results of a study recently published in […]
Addition of Taxol® to Cisplatin Improves Progression-Free Survival in Advanced Cervical Cancer According to a recent article published in the […]
Cisplatin Plus Topotecan Improves Survival Compared to Cisplatin Alone in Recurrent Cervical Cancer According to results presented at the 2004 annual meeting of the American Society of Gynecologic Oncologists, the chemotherapy combination consisting of cisplatin and topotecan improves survival compared to cisplatin alone in patients with recurrent or advanced cervical cancer. The cervix is a glandular organ that is located at the bottom of the uterus.
Paclitaxel Combined with Cisplatin Chemotherapy Appears More Effective than Cisplatin Therapy Alone for Treatment of Recurrent or Advanced Squamous Cell Carcinoma of the Cervix
Paclitaxel Combined with Cisplatin Chemotherapy Appears More Effective than Cisplatin Therapy Alone for Treatment of Recurrent or Advanced Squamous Cell […]